• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Acute Disease

Acute Disease - 176 Studies Found

Completed : Health Counseling and Exercise in Patients With Acute Leukemia - Pilot Study
: Acute Leukemia
: 2012-03-15
: Behavioral: Health counseling and exercise The intervention is initiated during chemotherapy treatment (
Completed : Pharmacokinetic Study of Busulfan in Allogeneic Stem Cell Transplantation in Adult Patients With Acute Leukemia
: Acute Leukemia
: 2011-12-19
: Drug: Busulfan Iv busulfan 1.6mg/kg q12h D1- D4 Othe
Completed : Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL)
: Acute Leukemia
: 2011-05-10
: Other: Exercise based multimodal intervention The intervention is initiated early, during treatment (con
Completed : Clove In The Treatment Of Relapsed Or Resistant Acute Leukemia In Children
: Acute Leukemia
: 2011-06-21
: Drug: Clofarabine VP 16 ciclophospahamide Clofarabine intravenously 2-hour infusion,dose 40 mg/m2, follo
Completed : Pilot Study of Hematopoietic Stem Cell Transplantation From Two Matched Sibling Donors in Treating Patients With Poor Prognosis Acute Leukemia and Advanced Lymphoproliferative Malignancies
: Relapsed and Refractory Acute Leukemia
: 2011-06-28
: Biological: Double matched sibling transplantation Patient
Completed : Impact of CT on Diagnosis of Acute Appendicitis
: Acute Appendicitis
: 2011-06-17
: Other: CT scanning CT image of the abdomen included the area between the 3rd. lumber vertebra and the to
Active, not recruiting : POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients
:
  • Relapsed/Refractory AML
  • Relapsed/Refractory ALL
  • Secondary
    : 2011-03-11
    : Drug: Plerixafor Dose Escalation Plerixafor dose escalatio
Completed : Demonstration of Near Zero Antibiotic Prescribing for Acute Bronchitis
:
  • Bronchitis
  • Cough

: 2010-11-10
: Behavioral: Demonstration of near zero antibiotic prescribing for patients with acute bronchitis A contr
Completed : Study of IRNEA (Irinotecan, Etoposide, Cytarabine) for Refractory or Relapsed Acute Leukemia in Children and Adolescents
: Acute Leukemia
: 2010-11-08
: Drug: Irinotecan Chemotherapy: irinotecan, etoposide, and
Terminated : A Study for Patients With Acute Leukemia
: Acute Leukaemia
: 2010-10-01
: Drug: LY2523355 Administered intravenously for at least 2 cycles. Cycle length is 21 days. Participants
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.